Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Kwak, Jae-Yong  [Clear All Filters]
2023
Cho H, Yoon DHyun, Shin D-Y, Koh Y, Yoon S-S, Kim SJin, Do YRok, Lee G-W, Kwak J-Y, Park Y, et al. Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404). Cancer Res Treat. 2023.
2022
Kim KHa, Lee JHoon, Lee M, Kim H-G, Do YRok, Park Y, Oh SYong, Shin H-J, Kim WSeog, Park S-K, et al. Busulfan, Melphalan, and Etoposide (Bume) Showed an Equivalent Effect to Busulfan, Cyclophosphamide, and Etoposide (BuCE) as Conditioning Therapy for Autologous Stem Cell Transplantation in Patients with Relapsed or High Risk Non-Hodgkin's Lymphoma: A Mul. Cancer Res Treat. 2022.
Yi JHo, Jeong SHyun, Kim SJin, Yoon DHyun, Kang HJin, Koh Y, Kim JSeok, Lee W-S, Yang D-H, Do YRok, et al. Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean Cohorts. Cancer Res Treat. 2022.
2021
Stadtmauer EA, Sullivan KM, Idrissi MEl, Salaun B, Alonso AAlonso, Andreadis C, Anttila V-J, Bloor AJc, Broady R, Cellini C, et al. Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice. Hum Vaccin Immunother. 2021:1-11.
2020
Kim KHa, Kim WSeog, Kim SJin, Yoon DHyun, Suh C, Kang HJin, Choi CWon, Lee HSup, Bae SHwa, Park J, et al. Treatment with Intravenous Busulfan, Melphalan, and Etoposide (BuME) followed by Autologous Stem Cell Transplantation in Patients with Non-Hodgkin's Lymphoma: A Multicenter Study from the Consortium for Improving Survival of Lymphoma (CISL). Transpl Int. 2020.
2019
Kim H, Lee K-H, Sohn SKyun, Kim I, Kim S-H, Park Y, Choi JHye, Kwak J-Y, Kim MKyoung, Bae SHwa, et al. Effect of Stem Cell Source and Dose on Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Idiopathic Aplastic Anemia: Data from the Korean Aplastic Anemia Trials. Acta Haematol. 2019:1-12.
2018
Lee G-W, Park SWoo, Go S-I, Kim H-G, Kim MKyoung, Min C-K, Kwak J-Y, Bae S-B, Yoon S-S, Lee J-J, et al. The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma. Acta Haematol. 2018;140(3):146-156.
2014
Kook M-H, Yhim H-Y, Lee N-R, Song E-K, Kim HSun, Yim C-Y, Kwak J-Y. Successful treatment of myelodysplastic syndrome and Behcet colitis after allogeneic hematopoietic stem cell transplantation. Korean J Intern Med. 2014;29(1):123-5.
2013
Kim Y-J, Jang JHo, Kwak J-Y, Lee J-H, Kim H-J. Use of azacitidine for myelodysplastic syndromes: controversial issues and practical recommendations. Blood Res. 2013;48(2):87-98.